BACKGROUND: According to cross-sectional and acute experimental evidence, reducing sitting time should improve cardiometabolic health risk biomarkers. Furthermore, the improvements obtained may depend on whether sitting is replaced with standing or ambulatory activities. Based on data from the Stand Up Victoria multicomponent workplace intervention, we examined this issue using compositional data analysis-a method that can examine and compare all activity changes simultaneously. METHODS: Participants receiving the intervention (n = 136 ≥ 0.6 full-time equivalent desk-based workers, 65% women, mean ± SD age = 44.6 ± 9.1 yr from seven worksites) were asked to improve whole-of-day activity by standing up, sitting less, and moving more. Their changes in the composition of daily waking hours (activPAL-assessed sitting, standing, and stepping) were quantified then tested for associations with concurrent changes in cardiometabolic risk (CMR) scores and 14 biomarkers concerning body composition, glucose, insulin, and lipid metabolism. Analyses were by mixed models, accounting for clustering (3 months, n = 105-120; 12 months, n = 80-97). RESULTS: Sitting reduction was significantly (P < 0.05) associated only with lower systolic blood pressure at 3 months, and with CMR scores, weight, body fat, waist circumference, diastolic blood pressure, and fasting triglycerides, total/HDL cholesterol, and insulin at 12 months. Significant differences between standing and stepping were only observed for systolic blood pressure and insulin; both favored stepping. However, replacing sitting with standing was significantly associated only with improvements in CMR scores, whereas replacing sitting with stepping was significantly associated with CMR scores and six biomarkers. CONCLUSIONS: Improvements in several cardiometabolic health risk biomarkers were significantly associated with sitting reductions that occurred in a workplace intervention. The greatest degree and/or widest range of cardiometabolic benefits appeared to occur with long-term changes, and when increasing ambulatory activities. TRIAL REGISTRATION: ACTRN1211000742976.
BACKGROUND: According to cross-sectional and acute experimental evidence, reducing sitting time should improve cardiometabolic health risk biomarkers. Furthermore, the improvements obtained may depend on whether sitting is replaced with standing or ambulatory activities. Based on data from the Stand Up Victoria multicomponent workplace intervention, we examined this issue using compositional data analysis-a method that can examine and compare all activity changes simultaneously. METHODS:Participants receiving the intervention (n = 136 ≥ 0.6 full-time equivalent desk-based workers, 65% women, mean ± SD age = 44.6 ± 9.1 yr from seven worksites) were asked to improve whole-of-day activity by standing up, sitting less, and moving more. Their changes in the composition of daily waking hours (activPAL-assessed sitting, standing, and stepping) were quantified then tested for associations with concurrent changes in cardiometabolic risk (CMR) scores and 14 biomarkers concerning body composition, glucose, insulin, and lipid metabolism. Analyses were by mixed models, accounting for clustering (3 months, n = 105-120; 12 months, n = 80-97). RESULTS: Sitting reduction was significantly (P < 0.05) associated only with lower systolic blood pressure at 3 months, and with CMR scores, weight, body fat, waist circumference, diastolic blood pressure, and fasting triglycerides, total/HDL cholesterol, and insulin at 12 months. Significant differences between standing and stepping were only observed for systolic blood pressure and insulin; both favored stepping. However, replacing sitting with standing was significantly associated only with improvements in CMR scores, whereas replacing sitting with stepping was significantly associated with CMR scores and six biomarkers. CONCLUSIONS: Improvements in several cardiometabolic health risk biomarkers were significantly associated with sitting reductions that occurred in a workplace intervention. The greatest degree and/or widest range of cardiometabolic benefits appeared to occur with long-term changes, and when increasing ambulatory activities. TRIAL REGISTRATION: ACTRN1211000742976.
Authors: Mary E Rosenberger; Janet E Fulton; Matthew P Buman; Richard P Troiano; Michael A Grandner; David M Buchner; William L Haskell Journal: Med Sci Sports Exerc Date: 2019-03 Impact factor: 5.411
Authors: Purva Jain; John Bellettiere; Nicole Glass; Michael J LaMonte; Chongzhi Di; Robert A Wild; Kelly R Evenson; Andrea Z LaCroix Journal: J Gerontol A Biol Sci Med Sci Date: 2021-01-01 Impact factor: 6.053
Authors: Dori E Rosenberg; Mikael Anne Greenwood-Hickman; Jing Zhou; Andrea J Cook; Kayne D Mettert; Julie Cooper; David Arterburn; Beverly B Green; Callie Walsh-Bailey; Jacqueline Kerr; Neville Owen; David Dunstan; Jennifer B McClure Journal: Contemp Clin Trials Date: 2021-10-16 Impact factor: 2.226
Authors: John Bellettiere; Fatima Tuz-Zahra; Jordan A Carlson; Nicola D Ridgers; Sandy Liles; Mikael Anne Greenwood-Hickman; Rod L Walker; Andrea Z LaCroix; Marta M Jankowska; Dori E Rosenberg; Loki Natarajan Journal: J Meas Phys Behav Date: 2021-02-16
Authors: Bruno P Moura; Rogério L Rufino; Ricardo C Faria; Jeffer E Sasaki; Paulo Roberto S Amorim Journal: Int J Environ Res Public Health Date: 2019-08-27 Impact factor: 3.390
Authors: Jennifer M Blankenship; Elisabeth A H Winkler; Genevieve N Healy; Paddy C Dempsey; John Bellettiere; Neville Owen; David W Dunstan Journal: Med Sci Sports Exerc Date: 2021-12-01 Impact factor: 5.411
Authors: Lidewij R Renaud; Maaike A Huysmans; Hidde P van der Ploeg; Erwin M Speklé; Allard J van der Beek Journal: Int J Environ Res Public Health Date: 2020-06-08 Impact factor: 4.614
Authors: Sarah A Tabozzi; Simona G Di Santo; Flaminia Franchini; Federica Ratto; Matilde Luchi; Beatrice Filiputti; Luca P Ardigò; Claudio L Lafortuna Journal: Front Physiol Date: 2020-07-07 Impact factor: 4.566